Filter
Sort
2022 Special Edition, Issue 1
2022 Special Edition, Issue 1

Hepatitis B. Unlike Hep C, it’s not curable — yet. But as the research continues and the knowledge base continues to grow, the cure gets c...

Expires: 10.19.2024
Issue 12
Issue 12

Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV dr...

Expires: 10.10.2024
Issue 12
Issue 12

How aware are clinicians that MS should no longer be considered a “White people only” disease? What roles have race and ethnicity been sho...

Expires: 10.03.2024
Issue 11
Issue 11

For clinicians seeking to provide the most effective HIV management, choosing ART for treatment-experienced patients with resistance-associated mutati...

Expires: 09.26.2024
Issue 11
Issue 11

The widely held belief that “MS rarely affects Black Americans” has been disputed by recent data. Not only has the overall prevalence of m...

Expires: 09.19.2024
Sex Ed 101: HIV + Mental Health (in College Youth)
  • Webcast
Sex Ed 101: HIV + Mental Health (in College Youth)

Activity featuring interactive elements and visualizations to explore HIV prevention in college students by addressing stigma, mental health, and PrEP uptake.

Expires: 09.14.2024
Issue 6
Issue 6

The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three age...

Expires: 09.13.2024
Issue 10
Issue 10

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the add...

Expires: 09.06.2024
Issue 10
Issue 10

Where’s the newer MS research leading? How has our understanding of noninflammatory progressive MS changed? How might these findings affect what...

Expires: 08.24.2024
Issue 5
Issue 5

ETI — elexacaftor/tezacaftor/ivacaftor — is next-generation triple-combination CFTR modulator therapy. Its recent pivotal trials have show...

Expires: 08.22.2024
Issue 5
Issue 5

What was it like for a frontline critical care pulmonologist at the very beginning of the COVID-19 epidemic? On the frontlines as the epidemic became...

Expires: 07.19.2024
Issue 9
Issue 9

Obesity among people living with HIV is on the rise. What’s causing it? Is it a side effect of ART? From which regimens? What do we know and wha...

Expires: 07.18.2024
Issue 4
Issue 4

Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most curre...

Expires: 07.18.2024
Issue 3
Issue 3

Where’s the evidence about managing pulmonary exacerbations in people with cystic fibrosis? What actually defines an exacerbation? Do females an...

Expires: 07.18.2024
Issue 9
Issue 9

MS may not yet be “curable,” but research continues to improve currently available treatment options and assess the safety and efficacy of...

Expires: 07.06.2024
Issue 2
Issue 2

Race and ethnicity. How do they affect a patient’s ability to receive a timely and accurate cystic fibrosis diagnosis? How do the social determi...

Expires: 06.20.2024